Jihun Ahn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jihun Ahn has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Seung-Woon Rha
Cardiovascular Center and Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea
5 shared publications - Byoung Geol Choi
Department of Biomedical Laboratory Science, Honam University, Gwangju, Korea
3 shared publications HyeYon Yu
School of Nursing, College of Medicine, Soonchunhyang University, Asan, South Korea
3 shared publicationsByoung Geol Choi
Department of Biomedical Laboratory Science, Honam University, Gwangju, South Korea; Department of Cardiology, Gwangju Christian Hospital, Gwangju, South Korea
2 shared publicationsCheol Ung Choi
Cardiovascular Center Korea University Guro Hospital Seoul Korea
2 shared publicationsDong Joo Oh
Department of Cardiology, Naeun Hospital, Incheon, South Korea
2 shared publications
Latest Publications
- 9 October 2026
- Published by Elsevier in Atherosclerosis
- Vol. 422, 121919
Association of beta-blocker therapy with outcomes after ST-segment elevation myocardial infarction stratified by GRACE risk score: A nationwide registry analysis
- 9 October 2026
- Published by Elsevier in Atherosclerosis
- Vol. 422, 121919
Association of beta-blocker therapy with outcomes after ST-segment elevation myocardial infarction stratified by GRACE risk score: A nationwide registry analysis
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (4) , 211-217
Comparative Evaluation of Pre-Test Probability Models for Coronary Artery Disease with Assessment of a New Machine Learning-Based Model
Kim KA, et al. Yonsei Med J. 2025 Jan;66:e23. https://doi.org/10.3349/ymj.2024.0067
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (4) , 211-217
Open AccessComparative Evaluation of Pre-Test Probability Models for Coronary Artery Disease with Assessment of a New Machine Learning-Based Model
Kim KA, et al. Yonsei Med J. 2025 Jan;66:e23. https://doi.org/10.3349/ymj.2024.0067
- 8 September 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 102 (5) , 878-884
Long‐term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions
Background: Lesion length is related to worse clinical outcomes following percutaneous coronary intervention (PCI) for the treatment of chronic total occlusion (CTO). However, the data to confirm the association between extremely long lesions and clinical hard endpoints have been limited. Therefore, we investigated the impact of extremely long CTO lesions (≥50 mm, treated lesion length) on the long‐term clinical outcomes following successful PCI.Methods: A total of 333 consecutive patients with CTO who underwent successful PCI with drug‐eluting stents (DESs) were allocated to either the extremely long or the short CTO group according to their CTO lesion length. The 5‐year clinical outcomes were compared between the two groups. The incidence of myocardial infarction, cardiac death (CD), revascularization, and major adverse cardiovascular events (MACE) was higher in the extremely long CTO group. The 5‐year clinical outcomes were analyzed using the Cox hazard ratio (HR) model.Results: In the entire study population, the extremely long CTO lesion was an independent predictor for higher rate of revascularization, MACE, CD, or mortality.Conclusions: In our study, CTO patients with extremely long lesions (≥50 mm) who underwent successful PCI were associated with a higher risk of worse long‐term clinical outcomes, including hard clinical endpoints such as CD and mortality even in the DESs era.
- 8 September 2023
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 102 (5) , 878-884
Long‐term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions
Background: Lesion length is related to worse clinical outcomes following percutaneous coronary intervention (PCI) for the treatment of chronic total occlusion (CTO). However, the data to confirm the association between extremely long lesions and clinical hard endpoints have been limited. Therefore, we investigated the impact of extremely long CTO lesions (≥50 mm, treated lesion length) on the long‐term clinical outcomes following successful PCI.Methods: A total of 333 consecutive patients with CTO who underwent successful PCI with drug‐eluting stents (DESs) were allocated to either the extremely long or the short CTO group according to their CTO lesion length. The 5‐year clinical outcomes were compared between the two groups. The incidence of myocardial infarction, cardiac death (CD), revascularization, and major adverse cardiovascular events (MACE) was higher in the extremely long CTO group. The 5‐year clinical outcomes were analyzed using the Cox hazard ratio (HR) model.Results: In the entire study population, the extremely long CTO lesion was an independent predictor for higher rate of revascularization, MACE, CD, or mortality.Conclusions: In our study, CTO patients with extremely long lesions (≥50 mm) who underwent successful PCI were associated with a higher risk of worse long‐term clinical outcomes, including hard clinical endpoints such as CD and mortality even in the DESs era.
- 21 October 2021
- Published by Wiley in Echocardiography
- Vol. 38 (10) , 1787-1794
Effect of systolic dysfunction and elevated left ventricular end diastolic pressure on 3‐year clinical outcomes in patients with atrial fibrillation
Objectives: Systolic and diastolic dysfunctions are related to adverse clinical outcomes in patients with sinus rhythm. The aim of this study was to clarify the prognostic significance of systolic and diastolic dysfunctions in patients with persistent atrial fibrillation (AF).Methods: We evaluated the data of 114 consecutive patients with persistent AF who underwent measurement of LVEDP at our hospital between March 1, 2011 and December 31, 2014. The patients were divided into two groups according to the left ventricular ejection fraction (LVEF): LVEF < 50 (reduced ejection fraction, REF group) and LVEF ≥50 (preserved EF, PEF group). The PEF group was further divided into two subgroups according to the left ventricular end‐diastolic filling pressure (LVEDP): LVEDP > 15 mm Hg and LVEDP ≤ 15 mm Hg subgroups. The 3‐year clinical outcomes were compared between the PEF and REF groups and the LVEDP ≥15 mm Hg and LVEDP < 15 mm Hg groups.Results: During the 3‐year follow‐up period, the rate of heart failure (HF) hospitalization and incidence of AF with rapid ventricular rhythm (RVR) were higher in the REF group than in the PEF group. Multivariate analysis revealed that REF was the only significant predictor of HF hospitalization (hazard ratio, 4.71; 95% confidence interval, 1.48–15.02; p = 0.009).Conclusions: Our mid‐term follow‐up data demonstrated that systolic dysfunction was an important predictor of HF hospitalization in patients with AF. However, elevated LVEDP may not be associated with adverse mid‐term clinical outcomes in patients without systolic dysfunction.
- 21 October 2021
- Published by Wiley in Echocardiography
- Vol. 38 (10) , 1787-1794
Effect of systolic dysfunction and elevated left ventricular end diastolic pressure on 3‐year clinical outcomes in patients with atrial fibrillation
Objectives: Systolic and diastolic dysfunctions are related to adverse clinical outcomes in patients with sinus rhythm. The aim of this study was to clarify the prognostic significance of systolic and diastolic dysfunctions in patients with persistent atrial fibrillation (AF).Methods: We evaluated the data of 114 consecutive patients with persistent AF who underwent measurement of LVEDP at our hospital between March 1, 2011 and December 31, 2014. The patients were divided into two groups according to the left ventricular ejection fraction (LVEF): LVEF < 50 (reduced ejection fraction, REF group) and LVEF ≥50 (preserved EF, PEF group). The PEF group was further divided into two subgroups according to the left ventricular end‐diastolic filling pressure (LVEDP): LVEDP > 15 mm Hg and LVEDP ≤ 15 mm Hg subgroups. The 3‐year clinical outcomes were compared between the PEF and REF groups and the LVEDP ≥15 mm Hg and LVEDP < 15 mm Hg groups.Results: During the 3‐year follow‐up period, the rate of heart failure (HF) hospitalization and incidence of AF with rapid ventricular rhythm (RVR) were higher in the REF group than in the PEF group. Multivariate analysis revealed that REF was the only significant predictor of HF hospitalization (hazard ratio, 4.71; 95% confidence interval, 1.48–15.02; p = 0.009).Conclusions: Our mid‐term follow‐up data demonstrated that systolic dysfunction was an important predictor of HF hospitalization in patients with AF. However, elevated LVEDP may not be associated with adverse mid‐term clinical outcomes in patients without systolic dysfunction.
- Open Access
- 31 December 2018
- Published by Soonchunhyang Medical Research Institute in Soonchunhyang Medical Science
- Vol. 24 (2) , 152-159
Relationship between Echocardiographic Diastolic Indices and Invasively Measured Left Ventricular End-Diastolic Pressure in Chronic Atrial Fibrillation Patients with Preserved Left Ventricular Ejection Fraction
- 31 December 2018
- Published by Soonchunhyang Medical Research Institute in Soonchunhyang Medical Science
- Vol. 24 (2) , 152-159
Open AccessRelationship between Echocardiographic Diastolic Indices and Invasively Measured Left Ventricular End-Diastolic Pressure in Chronic Atrial Fibrillation Patients with Preserved Left Ventricular Ejection Fraction
- Open Access
Impact of Chronic Total Occlusion Lesion Length onSix-month Angiographic and 2-year Clinical Outcomes
Background: Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is known to be associated with improved clinical outcomes compared with failed CTO PCI. However, it is not clear whether the angiographic and clinical outcomes of long CTO lesionis different with those of short CTO lesion in the drug eluting stent (DES) era. Method sand Results: A total of 235 consecutive patients underwent successful CTO intervention were divided into two groups according the CTO lesion length. Six-month angiographic and two-year clinical outcomes were compared between the two groups. The baseline clinical characteristics were similar between the two groups except prior PCI was more frequent in long CTO group whereas bifurcation lesion was more frequent in the short CTO group. In-hospital complications were similar between the two groups except intimal dissection was more frequent in long CTO group. Both groups had similar angiographic outcomes at 6 months and clinical outcomes up to 2 years except the incidence of repeat PCI, predominantly target vessel revascularization (TVR) was higher in long CTO group. In multivariate analysis, long CTO was an important predictor for repeat PCI (OR;4.26, CI 1.53-11.9, p=0.006). Conclusion: The safety profile, angiographic and 2-year clinical outcomes were similar between the two groups except higher incidence of repeat PCI in long CTO group despite of successful PCI with DESs.
Open AccessImpact of Chronic Total Occlusion Lesion Length onSix-month Angiographic and 2-year Clinical Outcomes
Background: Successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is known to be associated with improved clinical outcomes compared with failed CTO PCI. However, it is not clear whether the angiographic and clinical outcomes of long CTO lesionis different with those of short CTO lesion in the drug eluting stent (DES) era. Method sand Results: A total of 235 consecutive patients underwent successful CTO intervention were divided into two groups according the CTO lesion length. Six-month angiographic and two-year clinical outcomes were compared between the two groups. The baseline clinical characteristics were similar between the two groups except prior PCI was more frequent in long CTO group whereas bifurcation lesion was more frequent in the short CTO group. In-hospital complications were similar between the two groups except intimal dissection was more frequent in long CTO group. Both groups had similar angiographic outcomes at 6 months and clinical outcomes up to 2 years except the incidence of repeat PCI, predominantly target vessel revascularization (TVR) was higher in long CTO group. In multivariate analysis, long CTO was an important predictor for repeat PCI (OR;4.26, CI 1.53-11.9, p=0.006). Conclusion: The safety profile, angiographic and 2-year clinical outcomes were similar between the two groups except higher incidence of repeat PCI in long CTO group despite of successful PCI with DESs.
- 1 July 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 238, 66-71
Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis
- 1 July 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 238, 66-71
Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis
- Open Access
- 25 June 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 302
Study design and rationale of the ‘Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial’: study protocol for a randomized controlled trial
The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels, whereas the balloon-expandable SCUBA™ stent (Medtronic) has higher radial stiffness and can afford more accurate placement without geographic miss, which is important in aortoiliac bifurcation lesions. To date, there have been no randomized control trials comparing efficacy and safety between the self-expanding stent and balloon-expandable stent in advanced atherosclerotic iliac artery disease. The purpose of our study is to examine primary patency (efficacy) and incidence of stent fracture and geographic miss (safety) between two different major representative stents, the self-expanding nitinol stent (COMPLETE-SE™) and the balloon-expanding cobalt-chromium stent (SCUBA™), in stenotic or occlusive iliac arterial lesions. This trial is designed as a prospective, randomized, multicenter trial to demonstrate a noninferiority of SCUBA™ stent to COMPLETE-SE™ stent following balloon angioplasty in iliac arterial lesions, and a total of 280 patients will be enrolled. The primary end point of this study is the rate of primary patency in the treated segment at 12 months after intervention as determined by catheter angiography, computed tomography angiography, or duplex ultrasound. The SENS-ILIAC trial will give powerful insight into whether the stent choice according to deployment mechanics would impact stent patency, geographic miss, or stent fracture in patients undergoing stent implantation in iliac artery lesions. National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier: NCT01834495 ), registration date: May 8, 2012
- 25 June 2016
- Published by Springer Nature in Trials
- Vol. 17 (1) , 302
Open AccessStudy design and rationale of the ‘Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial’: study protocol for a randomized controlled trial
The self-expandable COMPLETE™ stent (Medtronic) has greater elasticity, allowing it to regain its shape after the compression force reduces, and has higher trackability, thus is easier to maneuver through tortuous vessels, whereas the balloon-expandable SCUBA™ stent (Medtronic) has higher radial stiffness and can afford more accurate placement without geographic miss, which is important in aortoiliac bifurcation lesions. To date, there have been no randomized control trials comparing efficacy and safety between the self-expanding stent and balloon-expandable stent in advanced atherosclerotic iliac artery disease. The purpose of our study is to examine primary patency (efficacy) and incidence of stent fracture and geographic miss (safety) between two different major representative stents, the self-expanding nitinol stent (COMPLETE-SE™) and the balloon-expanding cobalt-chromium stent (SCUBA™), in stenotic or occlusive iliac arterial lesions. This trial is designed as a prospective, randomized, multicenter trial to demonstrate a noninferiority of SCUBA™ stent to COMPLETE-SE™ stent following balloon angioplasty in iliac arterial lesions, and a total of 280 patients will be enrolled. The primary end point of this study is the rate of primary patency in the treated segment at 12 months after intervention as determined by catheter angiography, computed tomography angiography, or duplex ultrasound. The SENS-ILIAC trial will give powerful insight into whether the stent choice according to deployment mechanics would impact stent patency, geographic miss, or stent fracture in patients undergoing stent implantation in iliac artery lesions. National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov identifier: NCT01834495 ), registration date: May 8, 2012
- Open Access
- 1 January 2015
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 88 (1) , 69
Isolated Right Ventricular Noncompaction Accompanied by Right Ventricular Failure
- 1 January 2015
- Published by Korean Association of Internal Medicine in The Korean Journal of Medicine
- Vol. 88 (1) , 69
Open AccessIsolated Right Ventricular Noncompaction Accompanied by Right Ventricular Failure